drugset / Trial / NCT06564987

Risk of Nerve Damage After Administration of Local Anesthesia

NCT06564987

Phase 1 Recruiting 80 enrolled Cleveland Dental Institute
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This research aims to evaluate of the risk of nerve damage following the administration of articaine 4% and lidocaine 2% for Inferior Alveolar nerve Block (IANB). A Randomized Controlled Clinical Trial will be conducted where the patient will be randomly assigned to one the two groups; articaine 4% and Lidocaine 2%. The type of LA will be concealed to the operator, investigators and assessors. The patients will be monitored for any aigns of nerve parathesia for 3 months after the procedure.

Timeline

Start
2024-01-01
Primary completion
2024-12-31
Completion
2025-03-31

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Articaine Other / unclassified 4 %
Comparator Lidocaine Other / unclassified 2 %
Comparator Epinephrine Other / unclassified

Indications

No indication recorded.